Tokyo, Japan

Chinami Mizoguchi

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignees: Hamamatsu University School of Medicine, Meiji Co., Ltd.. Active years: 2024.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Chinami Mizoguchi: Innovator in Mitochondrial Function Improvement

Introduction

Chinami Mizoguchi is a notable inventor based in Tokyo, Japan. She has made significant contributions to the field of biotechnology, particularly in the area of mitochondrial function. Her innovative work has led to the development of a unique agent aimed at enhancing mitochondrial performance.

Latest Patents

Chinami Mizoguchi holds a patent for an agent that improves mitochondrial function. This invention includes a lactic acid bacterium, a culture of the lactic acid bacterium, or a culture supernatant of the lactic acid bacterium. This patent represents her commitment to advancing health and wellness through scientific research.

Career Highlights

Throughout her career, Mizoguchi has been associated with prestigious institutions such as Hamamatsu University School of Medicine and Meiji Co., Ltd. Her work in these organizations has allowed her to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Some of her notable coworkers include Takashi Ito and Yukio Asami. Their collaborative efforts have further enriched the research environment and fostered innovation in their respective fields.

Conclusion

Chinami Mizoguchi is a pioneering inventor whose work in mitochondrial function improvement showcases her dedication to scientific advancement. Her contributions are valuable to the ongoing research in biotechnology and health.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…